| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 14, 2022 |
| Accession Number: | 0001104659-22-125841 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 14, 2022 |
| Accession Number: | 0001104659-22-125841 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
15F-12B - ECMOHO Ltd (0001763197) (Filer)
EFFECT - ECMOHO Ltd (0001763197) (Filer)
POS AM - ECMOHO Ltd (0001763197) (Filer)
SC 13G/A - ECMOHO Ltd (0001763197) (Subject)
SC 13G/A - ECMOHO Ltd (0001763197) (Subject)
SC 13G/A - ECMOHO Ltd (0001763197) (Subject)
SHANGHAI, China, March 17, 2022 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced that on March 16, 2022, the Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") approved the Company's request to transfer the listing of the Company's American Depositary Shares (the "ADSs") from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is expected to take effect at the opening of business on March 17, 2022. The transfer of the Company's listing to the Nasdaq Capital Market is not expected to have any impact on trading in the Company's ADS
SHANGHAI, China, Feb. 15, 2022 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, announced today that it will increase digital marketing efforts to achieve continuous positive marketing outcomes and profits. ECMOHO has partnered with B2C and B2B companies across industries and sectors to build brands, grow market share and increase loyalty and customer value with the right digital capabilities. ECMOHO has fully participated in Douyin to gain attention of younger audience. Through short video and live broadcasting, ECMOHO is benefiting from their strong fan base for disseminating heal
SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced a change in its board of directors (the "Board"). Mr. Greg Ye tendered to the Board his resignation as an independent director of the Board, the chair and a member of the audit committee of the Board and a member of the Nominating and Corporate Governance Committee of the Board for personal reasons, effective from December 1, 2021. Mr. Greg Ye's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practice. The Bo
SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced a change in its board of directors (the "Board"). Mr. Greg Ye tendered to the Board his resignation as an independent director of the Board, the chair and a member of the audit committee of the Board and a member of the Nominating and Corporate Governance Committee of the Board for personal reasons, effective from December 1, 2021. Mr. Greg Ye's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practice. The Bo
SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO", "we" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Operational Highlights Number of brands offered by the Company increased to 41 as of September 30, 2021 from 39 as of June 30, 2021.Number of brand partners offered by the Company increased to 30 as of September 30, 2021 from 28 as of June 30, 2021.The cumulative number of partnered healthcare experts and KOLs grew from 1,216 as of September 30, 2020 to 1,591 as of September 30, 2021.
Gainers Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. Avenue Therapeutics, Inc. (NASDAQ:ATXI) gained 105.9% to close at $0.44 after the company received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol. The company also announced the effectiveness of its 1-for-15 reverse split on Sept. 23. Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 46